Ahmed Bennis/X
Aug 21, 2026, 18:22
Ahmed Bennis: NOAC Use Is Associated With Slower Cognitive Decline in AF and Alzheimer’s Disease
Ahmed Bennis, Professor of Cardiology at Ibn Rochd University Hospital, shared a post on X about a recent article by Nanbo Zhu et al., published in European Heart Journal, adding:
“Oral anticoagulants, cognition, and clinical outcomes in atrial fibrillation and Alzheimer’s disease.
In patients with AF and AD, NOAC use was associated with modestly slower cognitive decline and more favourable effectiveness and safety profiles.”
Title: Oral anticoagulants, cognition, and clinical outcomes in atrial fibrillation and Alzheimer’s disease: a Swedish nationwide study
Authors: Nanbo Zhu, Hong Xu, Sara Garcia-Ptacek, Sumonto Mitra, Maria Eriksdotter
Other posts featuring Ahmed Bennis on Hemostasis Today.
-
Aug 21, 2026, 19:09Aphisit Thongthaisin: Admitted to Sorbonne University’s T2H University Diploma for 2026/2027
-
Aug 21, 2026, 19:07José Luis Ferreiro Gutiérrez: Proud to Be Elected Chairperson-Elect of the ESC Working Group on Thrombosis
-
Aug 21, 2026, 19:00Manuel Monreal: New RIETE Registry Data on VTE Recurrence and Bleeding During Anticoagulation
-
Aug 21, 2026, 18:39Ronak H. Mistry: Updated ASH ITP Guidelines Bring New Guidance for Managing ITP
-
Aug 21, 2026, 18:12Irtiza Hasan: AI-Predicted Erythropoietin Dosing Matches Physician-Guided Dosing
-
Aug 21, 2026, 17:55Rosna Kerdson: The Role of Plasma in Modern Medicine
-
Aug 21, 2026, 17:41Abdul Mannan: Type 2N VWD Can Wear Haemophilia A’s Lab Coat
-
Aug 21, 2026, 17:33Ursula Porage Dona: How Data Can Strengthen Advocacy for Better Patient Outcomes
-
Aug 21, 2026, 17:18Nandini Pethe: Microhealth Can Be as Simple as Logging Treatments and Bleeds